adenosine has been researched along with Anochlesia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (62.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Borroto-Escuela, DO; Carlsson, J; Ciruela, F; Crans, RAJ; Fores-Pons, R; Fuxe, K; Lopez-Cano, M; Narváez, M; Romero-Fernandez, W; Taura, JJ | 1 |
| Konieczny, J; Pietraszek, M; Wardas, J | 1 |
| Cristalli, G; Morelli, M; Pinna, A; Volpini, R | 1 |
| Hauber, W; Münkle, M | 2 |
| Modabber, M; Sabetkasai, M; Zarrindast, MR | 1 |
| Kanda, T; Nakamura, J; Shimada, J; Shiozaki, S; Suzuki, F | 1 |
| Jarvis, MF; Martin, GE; Rossi, DJ | 1 |
| Chopde, CT; Ghosh, AK; Mandhane, SN | 1 |
| Ferré, S; Fuxe, K; Ogren, SO; Rimondini, R | 1 |
| Dorsa, DM; Ward, RP | 1 |
| Ichikawa, S; Kitamura, S; Kuwana, Y; Nakamura, J; Shiozaki, S; Yamada, K | 1 |
| Abraham, E; Chopde, CT; Khisti, RT | 1 |
| Beilstein, MA; Chen, JF; Cuellar, B; Fink, JS; Grandy, DK; Hackett, E; Impagnatiello, F; Low, MJ; Moratalla, R; Ongini, E; Rubinstein, M; Schwarzschild, MA | 1 |
| Hauber, W; Müller, CE; Nagel, J; Neuscheler, P | 1 |
| Ferré, S; Fuxe, K; Rubio, A | 1 |
16 other study(ies) available for adenosine and Anochlesia
| Article | Year |
|---|---|
The mGlu
Topics: Adenosine; Animals; Catalepsy; Dopamine; Haloperidol; HEK293 Cells; Humans; Mice; Parkinson Disease; Protein Subunits; Rats; Receptor, Adenosine A2A; Receptors, Dopamine D2 | 2022 |
Influence of CGS 21680, a selective adenosine A(2A) agonist, on the phencyclidine-induced sensorimotor gating deficit and motor behaviour in rats.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Catalepsy; Corpus Striatum; Dopamine Agonists; Enkephalins; Hallucinogens; In Situ Hybridization; Lameness, Animal; Male; Motor Activity; Muscle Rigidity; Nucleus Accumbens; Phencyclidine; Phenethylamines; Protein Precursors; Rats; Rats, Wistar; Reflex, Startle; RNA, Messenger; Rotarod Performance Test | 2003 |
New adenosine A2A receptor antagonists: actions on Parkinson's disease models.
Topics: Adenine; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Binding, Competitive; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Drug Synergism; Levodopa; Male; Molecular Structure; Parkinson Disease; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Tritium | 2005 |
Stimulation of adenosine A2a receptors in the rat striatum induces catalepsy that is reversed by antagonists of N-methyl-D-aspartate receptors.
Topics: 2-Amino-5-phosphonovalerate; Adenosine; Animals; Anticonvulsants; Catalepsy; Corpus Striatum; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Globus Pallidus; Male; Neural Pathways; Neuroprotective Agents; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stimulation, Chemical | 1995 |
Influences of different adenosine receptor subtypes on catalepsy in mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Catalepsy; Dose-Response Relationship, Drug; Drug Interactions; Mice; Phenylisopropyladenosine; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Theophylline; Vasodilator Agents | 1993 |
KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.
Topics: Adenosine; Administration, Oral; Animals; Antihypertensive Agents; Benserazide; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Mice; Phenethylamines; Purinergic Antagonists; Xanthines | 1994 |
Adenosine agonists reduce conditioned avoidance responding in the rat.
Topics: Adenosine; Animals; Antipsychotic Agents; Avoidance Learning; Binding, Competitive; Caffeine; Catalepsy; Dose-Response Relationship, Drug; Electroshock; Female; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, Purinergic; Receptors, Purinergic P1 | 1993 |
Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen.
Topics: Adenosine; Animals; Catalepsy; Caudate Nucleus; Dopamine D2 Receptor Antagonists; Male; Microinjections; Motor Activity; Neostriatum; Nucleus Accumbens; Phenethylamines; Purinergic P1 Receptor Agonists; Putamen; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Salicylamides | 1997 |
Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Catalepsy; Dopamine Antagonists; Haloperidol; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Scopolamine; Theobromine; Theophylline; Xanthines | 1997 |
Adenosine A2A agonists: a potential new type of atypical antipsychotic.
Topics: Adenosine; Animals; Antihypertensive Agents; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dose-Response Relationship, Drug; Locomotion; Male; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1 | 1997 |
Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
Topics: Adenosine; Animals; Antipsychotic Agents; Behavior, Animal; Caffeine; Catalepsy; Clozapine; Corpus Striatum; Cyclic AMP; Dopamine D2 Receptor Antagonists; Gene Expression Regulation; Genes, fos; GTP-Binding Protein alpha Subunits, Gs; Haloperidol; Nerve Tissue Proteins; Neurons; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Purinergic P1; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Second Messenger Systems; Serotonin; Serotonin Antagonists; Theophylline | 1999 |
Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Caffeine; Catalepsy; Dopamine Agents; Hypokinesia; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenethylamines; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Reserpine; Theophylline | 1999 |
GABAergic involvement in motor effects of an adenosine A(2A) receptor agonist in mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Amphetamine; Animals; Catalepsy; Dopamine Agents; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Hyperkinesis; Male; Mice; Motor Activity; Phenethylamines; Purinergic P1 Receptor Agonists; Receptor, Adenosine A2A; Receptors, Dopamine D2 | 2000 |
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.
Topics: Adenosine; Amphetamines; Animals; Caffeine; Catalepsy; Corpus Striatum; Dopamine Antagonists; Enkephalins; Gene Expression; Haloperidol; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic P1; RNA, Messenger | 2001 |
Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.
Topics: Adenosine; Animals; Benzazepines; Catalepsy; Caudate Nucleus; Dopamine Antagonists; Drug Interactions; Male; Phosphodiesterase Inhibitors; Prodrugs; Purinergic P1 Receptor Antagonists; Putamen; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic P1; Sulpiride; Theophylline; Xanthines | 2001 |
Stimulation of adenosine A2 receptors induces catalepsy.
Topics: Adenosine; Animals; Azepines; Catalepsy; Male; Phenethylamines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Purinergic; Synaptic Transmission; Theophylline | 1991 |